Invasive lobular carcinoma (ILC) is a clinically and molecularly distinct disease
ILCs show CDH1 and PTEN loss, AKT activation, and mutations in TBX3 and FOXA1
Proliferation and immune-related gene expression signatures define 3 ILC subtypes
Genetic features classify mixed tumors into lobular-like and ductal-like subgroups